Cargando…
GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson’s Disease
Finding novel biomarkers for Parkinson’s disease (PD) is crucial for early disease diagnosis, severity assessment and identifying novel disease-modifying drug targets. Our study aimed at investigating the GATA3 mRNA levels in whole blood samples of idiopathic PD (iPD) patients with different disease...
Autores principales: | Acharya, Shubhra, Lumley, Andrew I., Zhang, Lu, Vausort, Mélanie, Devaux, Yvan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298393/ https://www.ncbi.nlm.nih.gov/pubmed/37373190 http://dx.doi.org/10.3390/ijms241210040 |
Ejemplares similares
-
Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
por: Acharya, Shubhra, et al.
Publicado: (2021) -
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease
por: Acharya, Shubhra, et al.
Publicado: (2020) -
The circular RNA MICRA for risk stratification after myocardial infarction()
por: Salgado-Somoza, Antonio, et al.
Publicado: (2017) -
HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients
por: Greco, Simona, et al.
Publicado: (2023) -
Regulation of N6-Methyladenosine after Myocardial Infarction
por: Vausort, Mélanie, et al.
Publicado: (2022)